Systematic Review: Antimicrobial Urinary Catheters To Prevent Catheter-Associated Urinary Tract Infection in Hospitalized Patients

  1. James R. Johnson, MD;
  2. Michael A. Kuskowski, PhD; and
  3. Timothy J. Wilt, MD, MPH
  1. From Veterans Affairs Medical Center and University of Minnesota, Minneapolis, Minnesota.
    1. Figure 1.
      View larger version:
      Figure 1. Literature search and selection process.
    2. Figure 2. End point is proportion of participants (or catheters) developing catheter-associated bacteriuria. Three trials examined nitrofurazone catheters, 4 pre-1995 trials examined silver-alloy catheters, and 5 post-1995 trials examined silver-alloy catheters. The risk ratio is indicated by the horizontal position of the solid black squares. The 95% CIs around the risk ratios are indicated by the width of the solid lines.
      View larger version:
      Figure 2. End point is proportion of participants (or catheters) developing catheter-associated bacteriuria. Three trials examined nitrofurazone catheters, 4 pre-1995 trials examined silver-alloy catheters, and 5 post-1995 trials examined silver-alloy catheters. The risk ratio is indicated by the horizontal position of the solid black squares. The 95% CIs around the risk ratios are indicated by the width of the solid lines. Outcomes (total and stratified) of randomized and quasi-randomized clinical trials of currently marketed antimicrobial urinary catheters.
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med January 17, 2006 vol. 144 no. 2 116-126
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. November 3, 2009, 151 (9)
    1. Alert me to current issues